Pro-sys
Oral Wound Cleanser
Forward Science Technologies Llc
Human Otc Drug
NDC 70275-201Pro-sys also known as Oral Wound Cleanser is a human otc drug labeled by 'Forward Science Technologies Llc'. National Drug Code (NDC) number for Pro-sys is 70275-201. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Pro-sys drug includes Hydrogen Peroxide - 15 mg/mL . The currest status of Pro-sys drug is Active.
Drug Information:
| Drug NDC: | 70275-201 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Pro-sys |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Oral Wound Cleanser |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Forward Science Technologies Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | HYDROGEN PEROXIDE - 15 mg/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | BUCCAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 16 May, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 25 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part356 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Forward Science Technologies LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 205336
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0370275937135
|
| UPC stands for Universal Product Code. |
| UNII: | BBX060AN9V
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 70275-201-16 | 473 mL in 1 BOTTLE (70275-201-16) | 16 May, 2022 | N/A | No |
| 70275-201-28 | 3785 mL in 1 BOTTLE (70275-201-28) | 16 May, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose oral debriding agent / oral wound cleanser
Product Elements:
Oxistom oral wound cleanser xylitol methyl salicylate propylene glycol polyoxyl 40 hydrogenated castor oil water hydrogen peroxide hydrogen peroxide pro-sys oral wound cleanser xylitol methyl salicylate propylene glycol polyoxyl 40 hydrogenated castor oil water hydrogen peroxide hydrogen peroxide
Indications and Usage:
Uses ⢠aids in the removal of phlegm, mucus, or other secretions associated with occasional sore mouth. ⢠for temporary use in cleansing minor wounds or minor gum inflammation resulting from minor dental procedures, dentures, orthodontic appliances, accidental injury, or other irritations of the mouth and gums. ⢠for temporary use to cleanse canker sores. ⢠assists in the removal of foreign material from minor oral wounds.
Warnings:
Warnings do not use this product for more than 7 days unless directed by a dentist or physician. when using this product, do not swallow. stop use and ask a dentist or physician if: ⢠sore mouth symptoms do not improve in 7 days; ⢠irritation, pain, or redness persists or worsens; ⢠swelling, rash, or fever develops.
Dosage and Administration:
Directions ⢠adults and children 2 years of age or older: rinse half a capful (two teaspoons or 10 ml) around the mouth over the affected area for at least 1 minute, then spit out. ⢠use up to 4 times daily after meals and at bedtime or as directed by a dentist or physician. ⢠children under 12 years of age should be supervised in the use of the product. ⢠children under 2 years of age: consult a dentist or physician.
Directions ⢠adults and children 2 years of age or older: rinse half a capful (two teaspoons or 10 ml) around the mouth over the affected area for at least 1 minute, then spit out. ⢠use up to 4 times daily after meals and at bedtime or as directed by a dentist or physician. ⢠children under 12 years of age should be supervised in the use of the product. ⢠children under 2 years of age: consult a dentist or physician.
Package Label Principal Display Panel:
Oxistom
Prosys 16oz
Further Questions:
Questions? 1-855-696-7254